A study published in the International Journal of Risk & Safety in Medicine has linked the thimerosal-free HibTITER pediatric vaccine to 19 different medical conditions, including some life-threatening side effects. The vaccine was sold by Wyeth from 2003 to 2007 and was marketed as safe after it was reformulated to remove thimerosal, a type of mercury, following public outcry.
The research, conducted by Children’s Health Defense (CHD) scientists, compared adverse events in children who received HibTITER to those who received other Hib vaccines. The results revealed significant health risks among the recipients of HibTITER, which was removed from the market by Pfizer in 2007.
Key Findings:
- HibTITER was linked to 19 medical conditions, including respiratory, gastrointestinal, dermatologic, and ear/nose/throat issues.
- The study found that the rates of adverse effects from HibTITER were “significantly higher” compared to other Hib vaccines.
- Data was analyzed from the Florida Medicaid database and the Vaccine Adverse Event Reporting System (VAERS).
Vaccine Safety Concerns: The HibTITER vaccine, which was used between 2003 and 2007, was part of an effort to eliminate thimerosal from vaccines. However, research points to troubling side effects and a significant number of adverse events, some of which were not listed as potential side effects on the product’s label.
The research found:
- High incidences of respiratory illnesses like asthma and influenza.
- Gastrointestinal problems such as colitis, enteritis, and gastroenteritis.
- Other health conditions including common colds and tuberculosis.
Despite widespread concerns, no action was taken by the FDA or CDC to address these findings before Wyeth discontinued the vaccine. It is estimated that 35 million Americans received HibTITER during its time on the market, and many of them may now be experiencing long-term effects.
This research casts doubt on the safety of the HibTITER vaccine and raises questions about the effectiveness of safety protocols in place at the time. As a result, many who received the vaccine as infants may be at risk for various health conditions as adults.
The study calls for more rigorous safety studies before vaccines are approved for public use, emphasizing the importance of transparency and accountability in the vaccine approval process.
Related news:
New Findings Reveal Undeclared Heavy Metals and Chemicals in COVID-19 Vaccines
New Study Reveals Potential Heart Risks Linked to mRNA COVID Shots
